We are live on ! Find out more
PALI icon

Palisade Bio
PALI

6 hedge funds and large institutions have $68.5M invested in Palisade Bio in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

79% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $736K

50% more funds holding

Funds holding: 4 → 6 (+2)

39% more capital invested

Capital invested by funds: $49.5M → $68.5M (+$19.1M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
$1.32M
Puts
$736K
Net Calls
+$581K
Net Calls Change
+$347K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.7M
2
BIT
BlackRock Institutional Trust
California
+$4.7M
3
State Street
State Street
Massachusetts
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$4.7M
2
FAM
Fred Alger Management
New York
-$4.7M
3
SFM
Soros Fund Management
New York
-$803K
4
PAM
Panagora Asset Management
Massachusetts
-$500K
5
LP
LMR Partners
United Kingdom
-$296K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$426K – – –
TA
27
Teachers Advisors
New York
$407K – – –
MLICM
28
Metropolitan Life Insurance Company (MetLife)
New York
$235K – – –
Bank of America
29
Bank of America
North Carolina
$227K – – –
NFA
30
Nationwide Fund Advisors
Ohio
$222K – – –
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$207K – – –
VKH
32
Virtu KCG Holdings
New York
$206K – – –
BA
33
BlackRock Advisors
Delaware
$204K – – –
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
$193K – – –
SG Americas Securities
35
SG Americas Securities
New York
$193K – – –
VOYA Investment Management
36
VOYA Investment Management
Georgia
$191K – – –
AIG
37
American International Group
New York
$190K – – –
GC
38
Guggenheim Capital
Illinois
$174K – – –
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$170K – – –
GT
40
Greenleaf Trust
Michigan
$169K – – –
WCM
41
Westend Capital Management
California
$165K – – –
ProShare Advisors
42
ProShare Advisors
Maryland
$141K – – –
BRWA
43
B. Riley Wealth Advisors
Florida
$137K – – –
Wells Fargo
44
Wells Fargo
California
$133K – – –
DC
45
Davenport & Co
Virginia
$120K – – –
KFS
46
KMS Financial Services
Washington
$117K – – –
CS
47
Cannell & Spears
New York
$105K – – –
MAA
48
Managed Account Advisors
New Jersey
$92K – – –
ECM
49
EagleClaw Capital Management
Massachusetts
$89K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$84K – – –
1
2
3 4

PALI Hedge Fund Activity: Q2 2014 in Review

6 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2014, worth a combined $68.5M — up 39% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PALI positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.7M. The largest seller was Credit Suisse, exiting entirely with an estimated $4.7M sold.

  • 6 institutional investors held Palisade Bio (PALI) as of Q2 2014, up from 4 in Q1 2014.
  • Funds reported $68.5M of Palisade Bio stock for Q2 2014, up 39% quarter-over-quarter.
  • 3 funds opened new Palisade Bio positions in Q2 2014 and 1 closed out, a net change of +2 holders.
  • The largest Palisade Bio buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.7M added.
  • The largest Palisade Bio seller in Q2 2014 was Credit Suisse, an estimated $4.7M sold.

Based on aggregated 13F filings for Q2 2014.